| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
40,578 |
37,601 |
$2.51M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
55,413 |
38,714 |
$2.06M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
59,304 |
55,507 |
$1.49M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
59,260 |
55,458 |
$1.48M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
21,754 |
17,687 |
$1.23M |
| 80053 |
Comprehensive metabolic panel |
153,366 |
138,504 |
$898K |
| 84443 |
Thyroid stimulating hormone (TSH) |
86,135 |
81,792 |
$843K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
152,951 |
134,013 |
$677K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
39,428 |
38,116 |
$648K |
| 80061 |
Lipid panel |
84,743 |
80,393 |
$627K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
35,347 |
33,792 |
$551K |
| 87660 |
|
28,671 |
27,304 |
$417K |
| 87480 |
|
28,689 |
27,317 |
$416K |
| 87510 |
|
28,669 |
27,299 |
$415K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
77,770 |
73,880 |
$406K |
| 36415 |
Collection of venous blood by venipuncture |
214,887 |
187,656 |
$391K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
74,779 |
68,512 |
$389K |
| 82728 |
|
45,032 |
43,037 |
$387K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
29,245 |
27,132 |
$387K |
| 80050 |
General health panel |
12,502 |
12,315 |
$356K |
| 86780 |
|
38,285 |
36,614 |
$346K |
| 86003 |
|
4,203 |
3,467 |
$301K |
| 86803 |
|
28,185 |
27,067 |
$265K |
| H0048 |
Alcohol and/or other drug testing: collection and handling only, specimens other than blood |
17,174 |
11,253 |
$255K |
| 84439 |
|
36,280 |
34,373 |
$207K |
| 82607 |
|
22,675 |
21,556 |
$194K |
| 84403 |
|
11,123 |
10,609 |
$194K |
| 86481 |
|
2,795 |
2,676 |
$158K |
| 87077 |
|
29,483 |
26,113 |
$154K |
| 81229 |
|
232 |
221 |
$153K |
| 87186 |
|
28,244 |
25,770 |
$145K |
| 87340 |
|
20,402 |
19,556 |
$140K |
| 87070 |
|
21,950 |
20,808 |
$131K |
| 82670 |
|
6,314 |
6,105 |
$125K |
| 85027 |
|
33,493 |
30,783 |
$123K |
| 83550 |
|
23,484 |
22,408 |
$121K |
| 87522 |
Neg quan hep c or qual rna |
4,579 |
4,287 |
$118K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
943 |
927 |
$112K |
| 84702 |
|
9,317 |
7,187 |
$108K |
| 83516 |
|
7,880 |
6,987 |
$100K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25,234 |
21,440 |
$98K |
| 86762 |
|
9,376 |
9,007 |
$96K |
| 83540 |
|
24,845 |
23,705 |
$96K |
| 86235 |
|
1,928 |
1,468 |
$93K |
| 87902 |
|
557 |
517 |
$93K |
| 84270 |
|
6,285 |
5,961 |
$93K |
| 87081 |
|
19,091 |
18,494 |
$88K |
| 87536 |
|
1,942 |
1,808 |
$88K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
304 |
290 |
$82K |
| 83970 |
|
5,016 |
4,523 |
$81K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,068 |
2,311 |
$80K |
| 83001 |
|
6,001 |
5,833 |
$80K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
887 |
870 |
$79K |
| 86850 |
|
12,874 |
12,299 |
$78K |
| 87631 |
|
1,394 |
1,217 |
$76K |
| 82784 |
|
10,559 |
9,730 |
$76K |
| 83880 |
|
4,497 |
4,016 |
$74K |
| 84481 |
|
6,453 |
6,207 |
$72K |
| 82746 |
|
7,701 |
7,296 |
$67K |
| 82570 |
|
24,511 |
22,129 |
$66K |
| 83735 |
|
17,560 |
12,884 |
$64K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,408 |
3,168 |
$62K |
| 80074 |
|
2,291 |
2,082 |
$62K |
| 87088 |
|
12,497 |
11,613 |
$62K |
| 86706 |
|
8,764 |
8,211 |
$58K |
| 87529 |
|
2,275 |
2,200 |
$57K |
| 84153 |
|
6,144 |
5,776 |
$53K |
| 83002 |
|
3,897 |
3,788 |
$53K |
| 84146 |
|
3,995 |
3,830 |
$52K |
| 86480 |
|
1,323 |
1,249 |
$52K |
| 86140 |
|
15,138 |
13,802 |
$50K |
| 87046 |
|
4,382 |
3,334 |
$50K |
| 86038 |
|
6,328 |
6,018 |
$49K |
| 86704 |
|
6,424 |
5,974 |
$46K |
| 86258 |
|
1,689 |
1,536 |
$45K |
| 82274 |
|
4,749 |
4,639 |
$45K |
| 81001 |
|
28,718 |
25,777 |
$45K |
| 86376 |
|
4,433 |
4,257 |
$44K |
| 82785 |
|
3,541 |
3,387 |
$39K |
| 82043 |
|
13,992 |
13,059 |
$38K |
| 86665 |
|
1,622 |
1,424 |
$37K |
| 82105 |
|
3,270 |
3,071 |
$37K |
| 87328 |
|
3,981 |
3,692 |
$35K |
| 82951 |
|
3,604 |
3,539 |
$35K |
| 86696 |
|
2,767 |
2,660 |
$35K |
| 84144 |
|
2,339 |
2,179 |
$35K |
| 87209 |
|
2,765 |
2,599 |
$34K |
| 83993 |
|
2,423 |
2,346 |
$34K |
| 80076 |
|
7,158 |
6,573 |
$34K |
| 86800 |
|
3,056 |
2,941 |
$33K |
| 83921 |
|
3,169 |
3,000 |
$33K |
| 85652 |
|
18,500 |
17,418 |
$32K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
3,609 |
3,406 |
$32K |
| 87329 |
|
3,960 |
3,680 |
$32K |
| 82627 |
|
2,085 |
2,027 |
$32K |
| 83655 |
|
3,573 |
3,509 |
$31K |
| 86364 |
|
2,905 |
2,825 |
$30K |
| 86255 |
|
3,403 |
3,173 |
$29K |
| 87427 |
|
3,499 |
3,336 |
$28K |
| 82533 |
|
2,743 |
2,436 |
$28K |
| 86160 |
|
2,393 |
2,034 |
$28K |
| 84100 |
|
10,398 |
6,627 |
$27K |
| 84425 |
|
2,219 |
2,120 |
$27K |
| 80069 |
|
6,972 |
6,147 |
$27K |
| 86695 |
|
3,059 |
2,931 |
$27K |
| 87205 |
|
10,239 |
9,492 |
$27K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,065 |
1,038 |
$26K |
| 87338 |
|
2,752 |
2,650 |
$25K |
| 81511 |
|
325 |
301 |
$25K |
| 83690 |
|
5,599 |
5,301 |
$25K |
| 85610 |
|
12,368 |
9,872 |
$25K |
| 84480 |
|
2,597 |
2,461 |
$25K |
| 84156 |
|
11,100 |
9,738 |
$24K |
| 84550 |
|
8,405 |
7,416 |
$23K |
| 83520 |
|
1,894 |
1,765 |
$23K |
| 86769 |
|
1,118 |
1,087 |
$23K |
| 86361 |
|
1,560 |
1,469 |
$22K |
| 87045 |
|
3,496 |
3,333 |
$22K |
| 86900 |
|
10,790 |
10,295 |
$22K |
| 86901 |
|
10,640 |
10,154 |
$22K |
| 82977 |
|
4,093 |
3,663 |
$22K |
| 86141 |
|
2,553 |
2,451 |
$21K |
| 83525 |
|
2,437 |
2,220 |
$20K |
| 86694 |
|
1,619 |
1,377 |
$20K |
| 82950 |
|
6,043 |
5,877 |
$20K |
| 83498 |
|
978 |
948 |
$19K |
| 86200 |
|
2,378 |
2,205 |
$18K |
| 86231 |
|
1,538 |
1,506 |
$18K |
| 82247 |
|
6,784 |
4,302 |
$18K |
| 87507 |
|
55 |
53 |
$18K |
| 80164 |
|
3,048 |
2,493 |
$18K |
| 81508 |
|
518 |
500 |
$17K |
| 87177 |
|
2,762 |
2,598 |
$17K |
| 82239 |
|
1,355 |
1,177 |
$17K |
| 86787 |
|
1,718 |
1,577 |
$17K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,118 |
988 |
$16K |
| 80197 |
|
3,712 |
2,496 |
$16K |
| 86664 |
|
1,464 |
1,411 |
$16K |
| 84305 |
|
1,002 |
975 |
$16K |
| 82248 |
|
5,765 |
4,426 |
$16K |
| 86431 |
|
4,137 |
3,912 |
$15K |
| 87799 |
|
1,590 |
1,001 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
419 |
270 |
$14K |
| 82565 |
|
3,798 |
3,208 |
$14K |
| 86663 |
|
1,496 |
1,442 |
$14K |
| 86677 |
|
1,372 |
1,324 |
$14K |
| 83721 |
|
2,993 |
2,810 |
$13K |
| 84450 |
|
3,206 |
2,752 |
$12K |
| 82550 |
|
3,326 |
2,922 |
$12K |
| 82747 |
|
1,189 |
1,142 |
$12K |
| 85730 |
|
3,051 |
2,804 |
$11K |
| 86304 |
|
890 |
837 |
$11K |
| 80178 |
|
3,188 |
2,607 |
$11K |
| 82652 |
|
494 |
476 |
$11K |
| 80175 |
|
1,535 |
1,408 |
$11K |
| 86708 |
|
1,413 |
1,346 |
$11K |
| 86225 |
|
1,349 |
1,287 |
$11K |
| 87324 |
|
1,493 |
1,399 |
$11K |
| 0352U |
|
257 |
255 |
$11K |
| 83090 |
|
965 |
928 |
$10K |
| 84165 |
|
2,456 |
2,198 |
$10K |
| 82140 |
|
1,458 |
1,218 |
$10K |
| 84703 |
|
1,896 |
1,797 |
$10K |
| 84630 |
|
1,257 |
1,214 |
$10K |
| 86334 |
|
1,279 |
1,126 |
$10K |
| 84520 |
|
3,147 |
2,633 |
$10K |
| 86039 |
|
1,385 |
1,323 |
$9K |
| 83615 |
|
2,573 |
2,239 |
$9K |
| 84163 |
|
621 |
617 |
$9K |
| 81015 |
|
5,142 |
4,741 |
$9K |
| 83519 |
|
653 |
575 |
$9K |
| 84207 |
|
573 |
529 |
$8K |
| 82150 |
|
1,828 |
1,711 |
$7K |
| 87563 |
|
330 |
324 |
$7K |
| 83521 |
|
409 |
283 |
$7K |
| 80159 |
|
895 |
707 |
$7K |
| 85045 |
|
2,486 |
2,143 |
$7K |
| 82947 |
|
2,879 |
2,703 |
$7K |
| 87497 |
|
483 |
306 |
$7K |
| 85379 |
|
1,183 |
1,105 |
$7K |
| 84134 |
|
819 |
644 |
$7K |
| 82103 |
|
767 |
732 |
$7K |
| 83883 |
|
754 |
665 |
$6K |
| 82525 |
|
855 |
809 |
$6K |
| 85246 |
|
379 |
359 |
$6K |
| 87517 |
|
237 |
221 |
$6K |
| 86592 |
|
2,107 |
1,972 |
$6K |
| 82390 |
|
823 |
789 |
$6K |
| 84484 |
|
876 |
801 |
$5K |
| 86709 |
|
822 |
772 |
$5K |
| 87254 |
|
383 |
356 |
$5K |
| 86870 |
|
178 |
141 |
$5K |
| 86765 |
|
440 |
404 |
$4K |
| 82024 |
|
179 |
169 |
$4K |
| 80177 |
|
730 |
657 |
$4K |
| 85014 |
|
2,652 |
2,448 |
$4K |
| 85245 |
|
248 |
237 |
$4K |
| 84478 |
|
1,119 |
697 |
$4K |
| 88142 |
|
381 |
334 |
$4K |
| 85018 |
|
2,333 |
2,161 |
$4K |
| 85240 |
|
299 |
287 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
90 |
85 |
$4K |
| 87493 |
|
142 |
135 |
$3K |
| 86645 |
|
267 |
259 |
$3K |
| 86300 |
|
358 |
274 |
$3K |
| 86644 |
|
283 |
266 |
$3K |
| 87102 |
|
588 |
542 |
$3K |
| 87641 |
|
145 |
137 |
$3K |
| 86812 |
|
156 |
148 |
$3K |
| 87449 |
|
350 |
325 |
$3K |
| 87430 |
|
621 |
547 |
$3K |
| 82397 |
|
234 |
218 |
$2K |
| 82542 |
|
155 |
147 |
$2K |
| 87040 |
|
321 |
291 |
$2K |
| 84681 |
|
195 |
186 |
$2K |
| 88230 |
|
27 |
25 |
$2K |
| 88262 |
|
26 |
25 |
$2K |
| 84460 |
|
679 |
639 |
$2K |
| 82310 |
|
642 |
570 |
$2K |
| 82677 |
|
123 |
95 |
$2K |
| 86308 |
|
495 |
477 |
$2K |
| 86735 |
|
179 |
161 |
$2K |
| 82330 |
|
200 |
180 |
$2K |
| 86593 |
|
566 |
531 |
$2K |
| 83020 |
|
159 |
153 |
$1K |
| 86705 |
|
250 |
229 |
$1K |
| 84155 |
|
1,045 |
940 |
$1K |
| 86336 |
|
140 |
112 |
$1K |
| 80156 |
|
218 |
198 |
$1K |
| 83013 |
|
24 |
24 |
$1K |
| 80183 |
|
106 |
102 |
$1K |
| 86015 |
|
171 |
165 |
$937.40 |
| 82172 |
|
71 |
67 |
$917.36 |
| 87106 |
|
149 |
135 |
$897.08 |
| 86923 |
|
16 |
13 |
$799.24 |
| 86147 |
|
14 |
12 |
$770.34 |
| 86381 |
|
66 |
63 |
$754.10 |
| 82088 |
|
32 |
29 |
$740.06 |
| 87109 |
|
79 |
77 |
$737.38 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
1,089 |
650 |
$720.96 |
| 84154 |
|
97 |
91 |
$716.39 |
| 84244 |
|
54 |
52 |
$678.66 |
| 87075 |
|
158 |
137 |
$643.58 |
| 87101 |
|
120 |
116 |
$621.93 |
| 87539 |
|
20 |
17 |
$618.51 |
| 83021 |
|
45 |
44 |
$554.22 |
| 81596 |
|
28 |
26 |
$548.04 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
1,039 |
855 |
$501.70 |
| 84445 |
|
14 |
13 |
$500.48 |
| 86880 |
|
119 |
96 |
$491.25 |
| 84590 |
|
67 |
64 |
$487.73 |
| 87210 |
|
577 |
535 |
$484.20 |
| 81003 |
|
376 |
351 |
$467.07 |
| 84436 |
|
101 |
100 |
$441.89 |
| 83010 |
|
56 |
49 |
$434.18 |
| 83835 |
|
32 |
27 |
$381.76 |
| 82378 |
|
35 |
31 |
$363.63 |
| 80185 |
|
58 |
50 |
$338.54 |
| 85613 |
|
55 |
52 |
$329.72 |
| 0099U |
|
63 |
60 |
$312.50 |
| 88289 |
|
12 |
12 |
$259.91 |
| 88280 |
|
12 |
12 |
$252.67 |
| 83876 |
|
12 |
12 |
$249.20 |
| 84402 |
|
16 |
14 |
$233.18 |
| 82340 |
|
49 |
45 |
$205.58 |
| 89051 |
|
60 |
55 |
$186.72 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
164 |
148 |
$162.25 |
| 83695 |
|
338 |
324 |
$162.08 |
| 82530 |
|
13 |
12 |
$156.17 |
| 83630 |
|
13 |
12 |
$145.75 |
| 82610 |
|
12 |
12 |
$127.76 |
| 84446 |
|
16 |
14 |
$123.03 |
| 80201 |
|
14 |
13 |
$122.92 |
| 82040 |
|
44 |
37 |
$114.37 |
| 87350 |
|
14 |
13 |
$104.91 |
| 85384 |
|
16 |
13 |
$94.24 |
| 84132 |
|
35 |
25 |
$84.93 |
| 82085 |
|
12 |
12 |
$61.20 |
| 82465 |
|
12 |
12 |
$58.51 |
| 84075 |
|
13 |
13 |
$31.29 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
17 |
13 |
$25.27 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
116 |
98 |
$22.90 |
| 89321 |
|
13 |
13 |
$9.09 |